EU says it is too early to say if option to buy more J&J vaccines will be used

Coronavirus chronicle

Reuters
22 April, 2021, 05:15 pm
Last modified: 22 April, 2021, 05:18 pm
"I cannot say we are at the stage when the Commission can decide with member states whether or not to exercise the option. It's a bit premature," a spokesman for the Commission told a news conference
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

The European Commission said on Thursday it had not yet decided whether to take up or not the option to buy 200 million additional doses of the Johnson & Johnson Covid-19 vaccine.

"I cannot say we are at the stage when the Commission can decide with member states whether or not to exercise the option. It's a bit premature," a spokesman for the Commission told a news conference.

Under the contract with J&J, the EU has already ordered 200 million doses and has an option to buy another 200 million.

Related Topics

EU / Johnson & Johnson’s Covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.